Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email

29th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO)

November 21 – November 24, 2024

George R. Brown Convention Center Houston, TX

Add to Outlook Calendar

Are you in the neuro-oncology field and planning to attend the SNO Annual Meeting? NCI CBIIT’s Acting Director, Dr. Jill Barnholtz-Sloan, will be sharing her brain tumor research and moderating a panel discussion. Connect with her to learn more about her research and NCI’s data science efforts. You can find her at one of the following sessions!

Friday, November 22

7:45–7:55 a.m., CT (located in Grand Assembly C)

  • Oral Abstract Session: The increased risk of meningioma among individuals who are non-Hispanic Black is magnified among males and among those diagnosed with grade 2-3 tumors

7:55–8:05 a.m., CT (located in Grand Assembly C)

  • Oral Abstract Session: Genomic ancestry-related risk ratios for glioblastoma incidence among global populations and racial/ethnic groups within the United States

7:30–9:30 p.m., CT (located in Hall B3)

  • Poster: Sex differences in lung cancer brain metastases adverse events (DISP-04)
  • Poster: The impact of social determinants of health on treatment delays for glioblastoma (DISP-06)
  • Poster: History of type III immune hypersensitivity improves survival in glioblastoma (EPID-23)
  • Poster: Spatial transcriptomics enables statistical modeling of sex difference in gene co-expression network and immune landscape of glioblastoma (EPCO-44)

Saturday, November 23, 3:45–5:15 p.m., CT (located in Grand Ballroom A)

  • Panel: Statistics, sexual health and fertility, and special considerations in sexual and gender diverse AYA populations

Sunday, November 24, 10:15–11:45 a.m., CT (located in Grand Assembly C)

  • Oral Abstract Session: Multi-institutional validation of an AI-based model for prediction of tumor infiltration and future recurrence in patients with glioblastoma: results from the ReSPOND consortium

If you’re not attending the conference, but still want to connect with Jill, you can follow her via her X account, @NCIJBSloan!

Email